Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Smeyne, M
[1] Therapy involving Dihexa peptide shows potential for improving not just the symptoms of brain diseases but also the underlying causes
Fatty Acid Modifications: Exploiting the interactions between fatty acids and albumin to achieve metabolic stability and circulation, while using the self-assembly and ionic properties of fatty acids to prolong the drugs half-life
Unlike native IGF-1, which requires frequent administration due to its short half-life and extensive IGFBP binding, IGF-1 LR3's enhanced stability and bioavailability make it a more practical candidate for investigating growth factor-mediated tissue regeneration and metabolic regulation
US$ 20.79
US$ 29.57
US$ 24.17
